An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension
Authors:
Open Access
- 15 December 2022
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-13
Abstract
Background: Inhaled NO is a selective pulmonary vasodilator proven to be therapeutic for patients with pulmonary artery hypertension (PAH). The most common NO delivery system in clinical practice is cylinder-based, but unfortunately limited by its high costs, complicated delivery, and the requirement of an extensive supply chain, leaving vast unmet medical needs globally. Methods: To address the need for rapid, affordable, and safe production of nitric oxide (NO) for in-home inhalation therapy in patients with PAH. We developed a novel portable device to derive NO from a nitrite complex solution with a copper(II)-ligand catalyst, and further examined its effectiveness in a porcine model of PAH. This model was established by using female Bama miniature pig and induced by monocrotaline (MCT) administration. Results: This generator could rapidly and safely produce therapeutic NO at concentrations ranging from 0 to 100 parts per million (ppm) with the least disproportionated nitrogen dioxide (NO2) and byproducts. It could effectively alleviate pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in piglets with PAH, without causing major physiologic disruptions. Conclusions: Our electrochemical NO generator is able to produce the desired NO doses for pulmonary vasodilation in a safe and sustainable way, with low costs, which paves the way for its subsequent clinical trials in the patient with PAH and other common cardiopulmonary conditions with a high disease burden around the world.Keywords
Funding Information
- National Natural Science Foundation of China (U20A2018)
- Shanghai Outstanding Medical Academic Leader Program (2019LJ22)
- Shanghai Sailing Program (20YF1428700)
- Shanghai Chenguang Program (20CG23)
- Shanghai Pujiang Program (22PJ1410100)
This publication has 17 references indexed in Scilit:
- Pediatric Pulmonary HypertensionCirculation, 2015
- Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapyScience Translational Medicine, 2015
- Implementation of an Inhaled Nitric Oxide Protocol Decreases Direct Cost Associated With Its UseRespiratory Care, 2015
- Survival in Childhood Pulmonary Arterial HypertensionCirculation, 2012
- Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPDThorax, 2003
- Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 2000
- Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.Journal of Clinical Investigation, 1998
- Inhaled nitric oxide reduces human lung allograft dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Inhaled Nitric Oxide Selectively Reverses Human Hypoxic Pulmonary Vasoconstriction without Causing Systemic VasodilationAnesthesiology, 1993
- Inhaled nitric oxide in congenital heart disease.Circulation, 1993